Guangdong Biolight Meditech Balance Sheet Health
Financial Health criteria checks 3/6
Guangdong Biolight Meditech has a total shareholder equity of CN¥1.4B and total debt of CN¥632.5M, which brings its debt-to-equity ratio to 46.8%. Its total assets and total liabilities are CN¥2.5B and CN¥1.1B respectively.
Key information
46.8%
Debt to equity ratio
CN¥632.51m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥446.57m |
| Equity | CN¥1.35b |
| Total liabilities | CN¥1.15b |
| Total assets | CN¥2.50b |
Recent financial health updates
No updates
Recent updates
Guangdong Biolight Meditech Co., Ltd.'s (SZSE:300246) Shares Bounce 39% But Its Business Still Trails The Industry
Oct 08
Returns On Capital Signal Tricky Times Ahead For Guangdong Biolight Meditech (SZSE:300246)
Jun 07Why Investors Shouldn't Be Surprised By Guangdong Biolight Meditech Co., Ltd.'s (SZSE:300246) 30% Share Price Plunge
Jun 06There's No Escaping Guangdong Biolight Meditech Co., Ltd.'s (SZSE:300246) Muted Revenues Despite A 31% Share Price Rise
Mar 08Financial Position Analysis
Short Term Liabilities: 300246's short term assets (CN¥1.3B) exceed its short term liabilities (CN¥660.5M).
Long Term Liabilities: 300246's short term assets (CN¥1.3B) exceed its long term liabilities (CN¥485.2M).
Debt to Equity History and Analysis
Debt Level: 300246's net debt to equity ratio (13.8%) is considered satisfactory.
Reducing Debt: 300246's debt to equity ratio has increased from 37.9% to 46.8% over the past 5 years.
Debt Coverage: 300246's debt is not well covered by operating cash flow (6.2%).
Interest Coverage: Insufficient data to determine if 300246's interest payments on its debt are well covered by EBIT.